High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experience-Reference-Cited by-同舟云学术

High dose chemotherapy followed by autologous hematopoietic stem cell transplantation for advanced germ cell tumors: State of the art and a single-center experience

Published:2022-01 Issue: Volume:169 Page:103568
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Pierantoni Francesco^ORCID,Maruzzo Marco,Bimbatti Davide,Finotto Silvia,Marino Dario,Galiano Antonella,Basso Umberto,Zagonel Vittorina

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference47 articles.

1. High-Dose Chemotherapy and Autologous Stem Cell Transplant;Adra;Urol. Clin. North Am.,2019

2. High-dose chemotherapy and autologous peripheral-blood stem-cell transplantation for relapsed metastatic germ cell tumors: the indiana university experience;Adra;J. Clin. Oncol.,2017

3. Phase II trial of pembrolizumab in patients with platinum refractory germ-cell tumors: a Hoosier Cancer research Network Study GU14-206;Adra;Ann. Oncol.,2018

4. European Association of Urology. EAU guidelines on testicular cancer: 2011 update;Albers;Eur. Urol.,2011

5. First salvage treatment in patients with advanced germ cell cancer after cisplatin-based chemotherapy: analysis of a registry of the German Testicular Cancer study Group (GTCSG);Berger;J. Cancer Res. Clin. Oncol.,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: A case with atypical presentation oftesticular choriocarcinoma;Frontiers in Oncology;2024-07-17

2. High Dose Chemotherapy With Autologous Stem Cell Transplant for Patients With Advanced Germ Cell Tumors: Real-World Evidence From a Tertiary Cancer Center in Brazil;Clinical Genitourinary Cancer;2024-06

3. Pure testicular choriocarcinoma, a rare and highly malignant subtype with challenging treatment: A case report and review of the literature;Molecular and Clinical Oncology;2023-11-15

4. Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor;Journal of Clinical Medicine;2023-01-12

5. Clinical and prognostic analysis of 42 children with malignant rhabdoid tumor of the kidney: a 7-year retrospective multi-center study;BMC Pediatrics;2022-10-13